Revision as of 18:00, 5 May 2024 edit Mary Mark Ockerbloom (talk \| contribs) Autopatrolled, Event coordinators, Extended confirmed users 66,903 edits No edit summary ← Previous edit		Revision as of 18:02, 5 May 2024 edit undo Mary Mark Ockerbloom (talk \| contribs) Autopatrolled, Event coordinators, Extended confirmed users 66,903 edits →‎Career Next edit →
Line 25: Brem is known for her research, publishing and mentoring of students. Brem is a principal investigator for clinical trials including molecular imaging approaches for the improved detection of breast cancer.<ref name="JWI"/> She has published over 100 journal articles about breast cancer.<ref>{{cite web \|title=Rachel Brem - Publications Affiliations: Radiology The George Washington University, Washington, DC, United States \|url=https://neurotree.org/neurotree/publications.php?pid=737607 \|website=Neurotree}}</ref> She is the co-author with [[Christy Teal]] of the book ''No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right For You'' (2023).<ref name="Springen">{{cite journal \|last1=Springen \|first1=Karen \|title=No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right for You \|journal=Booklist \|date=April 15, 2023 \|volume=119 \|issue=16}}</ref> Brem advises legislative policy-makers on the importance of education, awareness, diagnosis and treatment of breast cancer.<ref name="JWI"/> She advocates for policies to require that women with dense breasts be informed of the possible need for additional types of breast cancer screenings. She recommends that medical plans should cover ~~additional~~ breast cancer screening methods such as MRIs and ultrasounds, not just mammograms.<ref name="Ovalle">{{cite news \|last1=Ovalle \|first1=David \|title=FDA sets national mammogram standards to protect women with dense breasts \|url=https://www.washingtonpost.com/health/2023/03/09/mammogram-standards-dense-breasts/ \|work=Washington Post \|date=9 March 2023}}</ref>In 2004, Brem helped to found the Brem Foundation to Defeat Breast Cancer, in support of research, education and clinical care.<ref name="Alliance"/> Brem is active in developing new technologies to decrease invasiveness and improve effectiveness of breast cancer diagnosis and treatment. These include Breast-specific gamma imaging (BSGI)<ref>{{Cite journal \|last=De Feo \|first=Maria Silvia \|last2=Sidrak \|first2=Marko Magdi Abdou \|last3=Conte \|first3=Miriam \|last4=Frantellizzi \|first4=Viviana \|last5=Marongiu \|first5=Andrea \|last6=De Cristofaro \|first6=Flaminia \|last7=Nuvoli \|first7=Susanna \|last8=Spanu \|first8=Angela \|last9=De Vincentis \|first9=Giuseppe \|date=2022-09-23 \|title=Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review \|url=https://pubmed.ncbi.nlm.nih.gov/36230540 \|journal=Cancers \|volume=14 \|issue=19 \|pages=4619 \|doi=10.3390/cancers14194619 \|issn=2072-6694 \|pmc=9559460 \|pmid=36230540}}</ref>, molecular breast imaging, ultrasound tomography, the use of artificial intelligence to increase accuracy of cancer detection, particularly in women with dense breast tissue, and the development of a noninvasive breath test for breast cancer detection.<ref name="SPM"/><ref name="Moeller">{{cite news \|last1=Moeller \|first1=Amy \|title=How Artificial Intelligence Is Improving Cancer Screening \|url=https://www.washingtonian.com/2023/09/27/how-artificial-intelligence-is-improving-cancer-screening/ \|work=Washingtonian \|date=27 September 2023}}</ref>

Rachel Brem: Difference between revisions